SCHEMBL3848971

SCHEMBL3848971

O=C(Nc1ccc(Cl)cc1F)c1ccc(Br)cc1F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.70
KMT2A Q03164 5/20 0.70
LMNA P02545 5/20 0.70
NPC1 O15118 4/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
GAA P10253 3/20 0.70
ALDH1A1 P00352 2/20 0.70
HPGD P15428 1/20 0.67
MAPT P10636 6/20 0.56
MEN1 O00255 3/20 0.56
HTT P42858 2/20 0.56
FLT1 P17948 1/20 0.56
FLT4 P35916 1/20 0.56
KDR P35968 1/20 0.56
TAS1R3 Q7RTX0 1/20 0.56
TAS1R1 Q7RTX1 1/20 0.56
TAS1R2 Q8TE23 1/20 0.56
TP53 P04637 3/20 0.53
CYP11B2 P19099 1/20 0.50
KCNMA1 Q12791 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670566 0.91 NPC1 (0.65) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL29803616 0.91 NPC1 (0.65) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL3846749 0.85 NPC1 (0.59) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL30897434 0.82 RAB9A (0.54) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL20898403 0.79 LMNA (0.66) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL14695827 0.79 NPC1 (0.55) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL31238369 0.78 TAS1R3 (0.86) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL29800850 0.77 NPC1 (0.55) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL23242595 0.77 NPC1 (0.55) RAB9AKMT2ALMNANPC1SMN1; SMN2
SCHEMBL3850184 0.77 SORT1 (0.73) RAB9AKMT2ALMNANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed